BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18481204)

  • 1. CCN5 Expression in mammals. II. Adult rodent tissues.
    Gray MR; Malmquist JA; Sullivan M; Blea M; Castellot JJ
    J Cell Commun Signal; 2007 Sep; 1(2):145-58. PubMed ID: 18481204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human.
    Jones JA; Gray MR; Oliveira BE; Koch M; Castellot JJ
    J Cell Commun Signal; 2007 Sep; 1(2):127-43. PubMed ID: 18481203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.
    Lake AC; Bialik A; Walsh K; Castellot JJ
    Am J Pathol; 2003 Jan; 162(1):219-31. PubMed ID: 12507905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN5, a secreted protein, localizes to the nucleus.
    Wiesman KC; Wei L; Baughman C; Russo J; Gray MR; Castellot JJ
    J Cell Commun Signal; 2010 Jun; 4(2):91-8. PubMed ID: 20531984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.
    Mason HR; Lake AC; Wubben JE; Nowak RA; Castellot JJ
    Mol Hum Reprod; 2004 Mar; 10(3):181-7. PubMed ID: 14981145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
    Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
    Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
    Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
    Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
    Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and biological function of the cellular communication network factor 5 (CCN5) in primary liver cells.
    Borkham-Kamphorst E; Meurer SK; Weiskirchen R
    J Cell Commun Signal; 2023 Jun; 17(2):307-320. PubMed ID: 37166689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
    Zhang CY; Xie X; Gao DS; Zhang CX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction.
    Zolfaghari S; Kaasbøll OJ; Ahmed MS; Line FA; Hagelin EMV; Monsen VT; Attramadal H
    J Cell Commun Signal; 2022 Sep; 16(3):377-395. PubMed ID: 34854055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2.
    Leask A
    J Cell Commun Signal; 2010 Oct; 4(3):155-6. PubMed ID: 21063505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
    Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
    J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells.
    Lake AC; Castellot JJ
    Cell Commun Signal; 2003 Nov; 1(1):5. PubMed ID: 14636425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen induces CCN5 expression in the rat uterus in vivo.
    Mason HR; Grove-Strawser D; Rubin BS; Nowak RA; Castellot JJ
    Endocrinology; 2004 Feb; 145(2):976-82. PubMed ID: 14605002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo.
    Rittié L; Perbal B; Castellot JJ; Orringer JS; Voorhees JJ; Fisher GJ
    J Cell Commun Signal; 2011 Mar; 5(1):69-80. PubMed ID: 21484592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation and functions of the matricellular CCN proteins induced by shear stress.
    Wang YK; Weng HK; Mo FE
    J Cell Commun Signal; 2023 Jun; 17(2):361-370. PubMed ID: 37191841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The matricellular protein CCN5 regulates podosome function via interaction with integrin αvβ 3.
    Myers RB; Wei L; Castellot JJ
    J Cell Commun Signal; 2014 Jun; 8(2):135-46. PubMed ID: 24488697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.